Literature DB >> 19678712

Efflux-mediated drug resistance in bacteria: an update.

Xian-Zhi Li1, Hiroshi Nikaido.   

Abstract

Drug efflux pumps play a key role in drug resistance and also serve other functions in bacteria. There has been a growing list of multidrug and drug-specific efflux pumps characterized from bacteria of human, animal, plant and environmental origins. These pumps are mostly encoded on the chromosome, although they can also be plasmid-encoded. A previous article in this journal provided a comprehensive review regarding efflux-mediated drug resistance in bacteria. In the past 5 years, significant progress has been achieved in further understanding of drug resistance-related efflux transporters and this review focuses on the latest studies in this field since 2003. This has been demonstrated in multiple aspects that include but are not limited to: further molecular and biochemical characterization of the known drug efflux pumps and identification of novel drug efflux pumps; structural elucidation of the transport mechanisms of drug transporters; regulatory mechanisms of drug efflux pumps; determining the role of the drug efflux pumps in other functions such as stress responses, virulence and cell communication; and development of efflux pump inhibitors. Overall, the multifaceted implications of drug efflux transporters warrant novel strategies to combat multidrug resistance in bacteria.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19678712      PMCID: PMC2847397          DOI: 10.2165/11317030-000000000-00000

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  792 in total

1.  A quorum-sensing autoinducer enhances the mexAB-oprM efflux-pump expression without the MexR-mediated regulation in Pseudomonas aeruginosa.

Authors:  Isao Sawada; Hideaki Maseda; Taiji Nakae; Hiroo Uchiyama; Nobuhiko Nomura
Journal:  Microbiol Immunol       Date:  2004       Impact factor: 1.955

Review 2.  Small multidrug resistance proteins: a multidrug transporter family that continues to grow.

Authors:  Denice C Bay; Kenton L Rommens; Raymond J Turner
Journal:  Biochim Biophys Acta       Date:  2007-08-24

3.  Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.

Authors:  Vincent Cattoir; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2008-07-21       Impact factor: 5.191

4.  High genetic variation in the multidrug transporter cmeB gene in Campylobacter jejuni and Campylobacter coli.

Authors:  Cédric Cagliero; Lucie Cloix; Axel Cloeckaert; Sophie Payot
Journal:  J Antimicrob Chemother       Date:  2006-05-30       Impact factor: 5.790

5.  Molecular epidemiology and prevalence of macrolide efflux genes mef(A) and mef(E) in Streptococcus pneumoniae obtained in Canada from 1997 to 2002.

Authors:  Aleksandra K Wierzbowski; Dean Swedlo; Dave Boyd; Michael Mulvey; Kim A Nichol; Daryl J Hoban; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

6.  Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF).

Authors:  Jürgen A Bohnert; Sabine Schuster; Eva Fähnrich; Rainer Trittler; Winfried V Kern
Journal:  J Antimicrob Chemother       Date:  2006-10-24       Impact factor: 5.790

7.  E. coli multidrug transporter MdfA is a monomer.

Authors:  Nadejda Sigal; Oded Lewinson; Sharon G Wolf; Eitan Bibi
Journal:  Biochemistry       Date:  2007-04-04       Impact factor: 3.162

8.  Catechin gallates inhibit multidrug resistance (MDR) in Staphylococcus aureus.

Authors:  Simon Gibbons; Elisabeth Moser; Glenn W Kaatz
Journal:  Planta Med       Date:  2004-12       Impact factor: 3.352

9.  The role of the Serratia marcescens SdeAB multidrug efflux pump and TolC homologue in fluoroquinolone resistance studied via gene-knockout mutagenesis.

Authors:  Sanela Begic; Elizabeth A Worobec
Journal:  Microbiology       Date:  2008-02       Impact factor: 2.777

10.  Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.

Authors:  Astrid Pérez; Delia Canle; Cristina Latasa; Margarita Poza; Alejandro Beceiro; María del Mar Tomás; Ana Fernández; Susana Mallo; Sonia Pérez; Francisca Molina; Rosa Villanueva; Iñigo Lasa; Germán Bou
Journal:  Antimicrob Agents Chemother       Date:  2007-07-16       Impact factor: 5.191

View more
  239 in total

1.  Assembly and channel opening of outer membrane protein in tripartite drug efflux pumps of Gram-negative bacteria.

Authors:  Yongbin Xu; Arne Moeller; So-Young Jun; Minho Le; Bo-Young Yoon; Jin-Sik Kim; Kangseok Lee; Nam-Chul Ha
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

Review 2.  Dosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic/pharmacodynamic target.

Authors:  Marilyn N Martinez; Mark G Papich; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2012-02-27       Impact factor: 5.191

3.  Efflux pumps are involved in the defense of Gram-negative bacteria against the natural products isobavachalcone and diospyrone.

Authors:  Victor Kuete; Bathélémy Ngameni; Jean G Tangmouo; Jean-Michel Bolla; Sandrine Alibert-Franco; Bonaventure T Ngadjui; Jean-Marie Pagès
Journal:  Antimicrob Agents Chemother       Date:  2010-02-16       Impact factor: 5.191

Review 4.  Engineering ecosystems and synthetic ecologies.

Authors:  Michael T Mee; Harris H Wang
Journal:  Mol Biosyst       Date:  2012-10

Review 5.  Bacterial Transcription as a Target for Antibacterial Drug Development.

Authors:  Cong Ma; Xiao Yang; Peter J Lewis
Journal:  Microbiol Mol Biol Rev       Date:  2016-01-13       Impact factor: 11.056

6.  Listeria monocytogenes strains selected on ciprofloxacin or the disinfectant benzalkonium chloride exhibit reduced susceptibility to ciprofloxacin, gentamicin, benzalkonium chloride, and other toxic compounds.

Authors:  Mira Rakic-Martinez; Douglas A Drevets; Vikrant Dutta; Vera Katic; Sophia Kathariou
Journal:  Appl Environ Microbiol       Date:  2011-10-14       Impact factor: 4.792

7.  Prevalence and role of efflux pump activity in ciprofloxacin resistance in clinical isolates of Klebsiella pneumoniae.

Authors:  S Aathithan; G L French
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-02-01       Impact factor: 3.267

8.  Efflux pumps of Mycobacterium tuberculosis play a significant role in antituberculosis activity of potential drug candidates.

Authors:  Meenakshi Balganesh; Neela Dinesh; Sreevalli Sharma; Sanjana Kuruppath; Anju V Nair; Umender Sharma
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

9.  MexEF-OprN multidrug efflux pump transporter negatively controls N-acyl-homoserine lactone accumulation in pseudomonas syringae pv. Tabaci 6605.

Authors:  Takahiro Sawada; Miho Eguchi; Seiya Asaki; Ryota Kashiwagi; Kousuke Shimomura; Fumiko Taguchi; Hidenori Matsui; Mikihiro Yamamoto; Yoshiteru Noutoshi; Kazuhiro Toyoda; Yuki Ichinose
Journal:  Mol Genet Genomics       Date:  2018-03-16       Impact factor: 3.291

10.  RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations.

Authors:  Eun-Jeong Yoon; Patrice Courvalin; Catherine Grillot-Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.